Vistra Corp. · Utilities
The price already needs more growth than analysts forecast, at both a 9% and an 8% discount rate.
Leverage plus AI customers, thin FCF. At a 12.0% margin the price needs +13.8%/yr against +8.8% consensus, a -12.9pt cushion against a 10.0pt cut (rule: drowns, -7.1pt at 15.3%).
Would recover if: hyperscaler load growth slips. We re-check this against analyst estimates every evening.
10 years, at a 12% margin analysts expect
+6.2%/yr over 10 years once faded to terminal growth
points off 3-year analyst growth
16 published targets
Linked to AMZN, META, MSFT, NVDA
Does the profit analysts build their margin on actually arrive as cash? Measured over the last 3 annual statements filed before this test. After stock-based pay, 271% of reported profit arrived as operating cash, so the analysts' margin stands.
How much of reported profit arrived as operating cash. Below 0.8× is a red flag.
Profit not backed by cash, as a share of assets, latest year. Above 10% is a red flag.
Staff paid in shares instead of cash, which flatters margins. Above 10% is a red flag.
Dilution of each share's claim on the business. Above 3% a year is a red flag.
Non-operating gains in the latest year. Above 25% is a red flag.
After capex. Shown for context: heavy investment is not bad earnings, so it is never solved under.
From the priced-in reconstruction of Nov 21, 2026. Its figures use that day's price and free-cash-flow margin, so they can differ from the stress test above.
At the price, Vistra sits below all 16 published models, whose targets of $169 to $255 (median $192) say the street sees 47% to 121% upside the market refuses to pay for.
Will the 2027 guidance step-up and the une模特led ~$700m from Meta/Cogentrix actually convert into earnings, or does Texas regulatory risk (moratoriums, ERCOT forward-price softness) erode it? The only wired measurements are segment revenue history and attention data, which can confirm realized revenue mix but cannot test forward contracts, regulatory outcomes, or power prices — so the crux is largely not settleable with the available tools.
What the price refuses to pay for, and the full reconstruction, on the VST quote page →A stress test of whether this narrative is still paid for by analyst forecasts, not a forecast that the stock will rise. The price-implied growth on its own has not predicted returns in our testing, and this list (sealed Nov 21, 2026) has not been graded yet. Cut sizes are assumptions. Not investment advice. Back to all names